My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Cell Div. 2009 Jun 2;4:10.

    Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy.

    Ullah Z, Lee CY, Depamphilis ML.

    National Institute of Child Health and Human Development, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892-2753, USA. depamphm@mail.nih.gov.

    ABSTRACT: Cyclin-dependent kinases (CDKs) play a central role in the orderly transition from one phase of the eukaryotic mitotic cell division cycle to the next. In this context, p27Kip1 (one of the CIP/KIP family of CDK specific inhibitors in mammals) or its functional analogue in other eukarya prevents a premature transition from G1 to S-phase. Recent studies have revealed that expression of a second member of this family, p57Kip2, is induced as trophoblast stem (TS) cells differentiate into trophoblast giant (TG) cells. p57 then inhibits CDK1 activity, an enzyme essential for initiating mitosis, thereby triggering genome endoreduplication (multiple S-phases without an intervening mitosis). Expression of p21Cip1, the third member of this family, is also induced in during differentiation of TS cells into TG cells where it appears to play a role in suppressing the DNA damage response pathway. Given the fact that p21 and p57 are unique to mammals, the question arises as to whether one or both of these proteins are responsible for the induction and maintenance of polyploidy during mammalian development.

    PMID: 19490616 [PubMed - in process]

    PMCID: PMC2697143

    Supplemental Content

    Click here to read Click here to read
    Write to the Help Desk